Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
Status: | Recruiting |
---|---|
Conditions: | Anemia, Hematology |
Therapuetic Areas: | Hematology |
Healthy: | No |
Age Range: | 19 - Any |
Updated: | 11/8/2014 |
Start Date: | February 2011 |
Contact: | Jonathan R Lindner, MD |
Email: | lindnerj@ohsu.edu |
Phone: | 5034948750 |
The purpose of this study is to examine how abnormal blood flow in the small vessels
(microvessels) of the heart, muscle and kidney in paroxysmal nocturnal hemoglobinuria (PNH)
or sickle cell disease leads to poor functioning of the heart and kidney. To test this
question, the investigators will perform imaging tests (contrast ultrasound perfusion
imaging) to look at the flow and function of these microvessels and compare this information
to heart and kidney function. To further look at this question, patients who have PNH will
be studied before and after starting a new drug (Soliris) that decreases damage to blood
cells. In patients with sickle cell disease, patients will be studied at baseline (not
during a pain crisis) and also during a pain crisis if one develops.
(microvessels) of the heart, muscle and kidney in paroxysmal nocturnal hemoglobinuria (PNH)
or sickle cell disease leads to poor functioning of the heart and kidney. To test this
question, the investigators will perform imaging tests (contrast ultrasound perfusion
imaging) to look at the flow and function of these microvessels and compare this information
to heart and kidney function. To further look at this question, patients who have PNH will
be studied before and after starting a new drug (Soliris) that decreases damage to blood
cells. In patients with sickle cell disease, patients will be studied at baseline (not
during a pain crisis) and also during a pain crisis if one develops.
Inclusion Criteria:
- Established diagnosis of PNH or SCD Age > 18 years old
Exclusion Criteria:
- Pregnant or lactating women Presence of significant right to left shunting Allergy to
ultrasound contrast agent Reactive airways disease Significant peripheral or coronary
artery disease
We found this trial at
1
site
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
Click here to add this to my saved trials